课题基金 / 基金详情

Covid-19 Test Management Platform

Covid-19 Test Management Platform
Covid-19 测试管理平台
批准号:
60293
负责人:
金额:
$6.32万
依托单位国家:
英国
项目类别:
Feasibility Studies
财政年份:
2020
资助国家:
英国
项目状态:
已结题
起止时间:
2020 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Covid-19 Test Management PlatformIs a distributed ledger technology (DLT) based unified platform for test kit suppliers, laboratories, data scientists, public health practitioners and policymakers. It will consist of a mobile based application, desktop consoles and platform integrated together to deliver an end to end process of collating, managing, recording and delivering test data to users. The test management platform provides the whole process of testing and a channel for the parties included. This will help the nation, individuals and companies as a whole.The system will leverage the immutability, availability and account structures offered by a fast DLT to offer:1. Stable data that is immutable and anonymous once uploaded2. Selected access to data - Users will be able to selectively delegate access to their test data based on account permissions3. Test kit suppliers will be able to track each test kit end to end4. Laboratories will be able to deliver test results securely and quickly directly to the user's application account5. The connectedness of the Distributed Ledger allows for large scale rollout of the system without accelerating costs. The platform will be accessible through secure internet connections6. The selected DLT is fast, scalable with free transactions and data recording, utilising off the shelf servers that are not as energy intensive as current blockchain mining nodesThe platform is suitable for any testing and is therefore reusable with minimum reconfiguration requirement. We submit that this platform will have a positive impact on the collaborative effort of tracking through testing, understanding and the development of vaccines and therapies for COVID-19\. This platform can also form the basis of tracking other pandemics and infectious diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
芽孢杆菌TR19-1对魔芋腐皮镰刀菌拮抗机理研究
1H/19F多核MRI术中可视化免疫抑制巨噬细胞定位脑胶质瘤浸润边界
ATPIF1调节线粒体膜电位影响靶向CD19 CAR-T细胞抗肿瘤活性的作用及机制
  • 批准号:
    2026JJ80001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    钟根深
  • 依托单位:
CD19/BCMA双靶向CAR-NK细胞治疗难治性SLE:作用机制与临床前转化研究
  • 批准号:
    2026JJ81339
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    谢希
  • 依托单位: